Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Osteoporosis
Interventions: OTHER: laboratory biomarker analysis|PROCEDURE: dual x-ray absorptiometry
Sponsor: ETOP IBCSG Partners Foundation
Collaborators: National Cancer Institute (NCI)|Breast International Group